2Socinski MA, Morris DE, Masters GA , et al. Chemotherapeutic management of stage IV non - small cell lung cancer. Chest,2003,123 ( 1 Suppl) :226 ~ 243. 被引量：1
3Bezjak A, Tu D , Seymour L , et al. Symptom improvement in lung cancer patients treated with erlotinb: Quality of life a- nalysis of the National Cancer Institute of Canada Clinical Trials Group StudyBR. 21. Clin Oncol,2006,24 (24) : 3 831 -3 837. 被引量：1
4Wackerman B, Nagrani T, Weinberg J,et al. Correlation between development of rash and efficacy in patients treated with the epidermal growth factor tyrosine kinase inhibitor erlotinib in two large phase III studies. Clin Cancer Res,2007, 13(13) :3 913 -3 921. 被引量：1
